Page Loading

Benchmarking measures for Scottish pharma services: biosafety testing


The aim of this research was to update a 2017 analysis of the European biosafety testing market position of Scottish based organisations (Benchmarking measures for Scottish pharma services).


The methodology consisted of a review of key players in the provision of biosafety testing in Europe, analysis of financial data and assumption-based modelling to estimate market share.


The 2017 estimate that Scottish based organisations had a 53% market share for European biosafety testing was recalculated at 58% based on 2019/2020 financial data.


The report does not make any recommendations.

Author Evolution Bioscience
Published Year 2021
Report Type Research
  • Business infrastructure
    Supporting key sectors
  • Sectors
    Chemical sciences